Proove® provides understandable and actionable information at the point of care to improve healthcare decisions for the nation’s largest and most expensive health condition – pain. In comparison to the level of sophistication used for heart disease or cancer, with tools such as blood tests, medical devices, genetic testing, and other advanced techniques to better understand the underlying disease and select treatment modalities, the diagnosis and treatment of pain is far behind. Proove’s predictive analytics platform improves health care decisions, and we deliver that information through precision medicine profiles. Proove helps clinicians, patients, and payers overcome the burden of pain.
There is a substantial difference for a patient when comparing a world without Proove versus a world with Proove. The current standard of care, if you can use those words, is highly inadequate for a patient. Using Proove, a patient is empowered to receive the treatment that will work best for them.
Patient benefits Include:
There is a substantial difference for a clinician when comparing a world without Proove versus a world with Proove. The current standard of care, if you can use those words, is highly inadequate for a physicians, physician assistants, nurse practitioners, and other clinicians treating chronic pain. Whereas clinicians should be considered heroes for trying to help patients overcome their pain, pain clinicians are under an unparalleled level of scrutiny for their use of medications, procedures, and laboratory testing. Using Proove, a clinician has objective information to improve their healthcare decisions, protect their patients, and protect their practice from the negative outcomes associated with pain management.
Clinician benefits Include:
There is a substantial difference for a payer when comparing a world without Proove versus a world with Proove. The current approaches are leading to rapidly increasing costs and poor outcomes. Using Proove, a payer can influence clinician decisions in unparalleled ways – rather than just having population health data to influence blanket policy decisions.
Payer benefits Include:
Proove is a proud member of the Coalition to Stop Opioid Abuse and the Collaborative for Effective Prescription Opioid Policies4. We have sponsored local non-profits as they support National Take Back Day initiatives, and we are interested in working with policy makers to help solve the prescription opioid abuse epidemic as well as reduce overall healthcare and disability costs.
Public policymakers desire solutions, but the current approaches put in place over the past several years are failing. Opioids now kill more people than gun homicides – less than a decade ago, gun homicides outpaced opioid deaths by more than 5 to 1.5
Clearly, law enforcement initiatives by the police, FBI, and US Attorney offices is not enough. Clearly, legislative efforts such as Prescription Drug Monitoring Programs are not enough. Just as we have a “moonshot” for cancer, Proove is leading a precision medicine initiative for the nation’s largest and most expensive health condition that is driving creation of the prescription opioid abuse epidemic. Proove seeks to partner with law enforcement, legislators, and policy makers to help solve this problem.
More than 52,000 Americans died from drug overdoses in 2015, a “drastic increase” from the previous year according to the CDC, fueled largely by deaths caused by heroin, fentanyl, and other illicit opioids. According to new data released by the CDC in December 2016, heroin deaths increased more than 20 percent from 2014 to 2015, and deaths linked to synthetic opioids such as fentanyl soared by more than 72 percent. The death rates “increased across all age groups 15 and older, in both sexes, and among all races/ethnicities.”6
The outcomes data clearly shows that conventional approaches are not working. This is why Proove is clearly positioned to be a partner with policymakers in delivering a solution.
Policymaker benefits are clear: